Caricamento...
Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA
BACKGROUND: The intravitreal anti-vascular endothelial growth factor treatments ranibizumab and aflibercept have proven efficacy in clinical trials, but their real world usage in central retinal vein occlusion (CRVO) has not been assessed. We therefore evaluated the treatment patterns of both drugs...
Salvato in:
| Pubblicato in: | Eye (Lond) |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4366471/ https://ncbi.nlm.nih.gov/pubmed/25572584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2014.308 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|